Form 4 for ENTX Entera Bio Ltd.
Accepted 2026-02-17 00:00:00 ET · period of report 2026-02-12 · accession 0001178913-26-000508 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-17 | 2026-02-12 | ENTX | Rubin Steven D | Dir | P - Purchase | $1.49 | +5,000 | 15.0K | +50% | +$7,450 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares, par value NIS 0.0000769 per share | 2026-02-12 | P | A | 5,000 | $1.49 | 15,000 | D | — | — |